Literature DB >> 28526534

3-Methylglutaconic aciduria, a frequent but underrecognized finding in carbamoyl phosphate synthetase I deficiency.

Dariusz Rokicki1, Magdalena Pajdowska2, Joanna Trubicka3, Meow-Keong Thong4, Elżbieta Ciara3, Dorota Piekutowska-Abramczuk3, Maciej Pronicki5, Roman Sikora6, Rijad Haidar7, Mariusz Ołtarzewski8, Ewa Jabłońska8, Premala Muthukumarasamy4, Pavai Sthaneswar9, Chin-Seng Gan4, Małgorzata Krajewska-Walasek3, Rosalba Carrozzo10, Daniela Verrigni10, Michela Semeraro11, Cristiano Rizzo11, Roberta Taurisano11, Bader Alhaddad12, Reka Kovacs-Nagy12, Tobias B Haack13, Carlo Dionisi-Vici11, Ewa Pronicka14, Saskia B Wortmann15.   

Abstract

The urea cycle disorder carbamoyl phosphate synthetase I deficiency is an important differential diagnosis in the encephalopathic neonate. This intoxication type inborn error of metabolism often leads to neonatal death or severe and irreversible damage of the central nervous system, even despite appropriate treatment. Timely diagnosis is crucial, but can be difficult on routine metabolite level. Here, we report ten neonates from eight families (finally) diagnosed with CPS1 deficiency at three tertiary metabolic centres. In seven of them the laboratory findings were dominated by significantly elevated urinary 3-methylglutaconic acid levels which complicated the diagnostic process. Our findings are both important for the differential diagnosis of patients with urea cycle disorders and also broaden the differential diagnosis of hyperammonemia associated with 3-methylglutaconic aciduria, which was earlier only reported in TMEM70 and SERAC1 defect.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28526534     DOI: 10.1016/j.cca.2017.05.023

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Two novel CPS1 mutations in a case of carbamoyl phosphate synthetase 1 deficiency causing hyperammonemia and leukodystrophy.

Authors:  Xihui Chen; Lijuan Yuan; Mao Sun; Qingbo Liu; Yuanming Wu
Journal:  J Clin Lab Anal       Date:  2018-01-04       Impact factor: 2.352

2.  Bezafibrate In Vivo Administration Prevents 3-Methylglutaric Acid-Induced Impairment of Redox Status, Mitochondrial Biogenesis, and Neural Injury in Brain of Developing Rats.

Authors:  Nevton Teixeira da Rosa-Junior; Belisa Parmeggiani; Mateus Struecker da Rosa; Nícolas Manzke Glänzel; Leonardo de Moura Alvorcem; Moacir Wajner; Guilhian Leipnitz
Journal:  Neurotox Res       Date:  2019-03-09       Impact factor: 3.911

3.  N-acetylglutamate synthase deficiency with associated 3-methylglutaconic aciduria: A case report.

Authors:  Arthavan Selvanathan; Kalliope Demetriou; Matthew Lynch; Michelle Lipke; Carolyn Bursle; Aoife Elliott; Anita Inwood; Leanne Foyn; Brett McWhinney; David Coman; Jim McGill
Journal:  JIMD Rep       Date:  2022-07-22

4.  Novel Neonatal Variants of the Carbamoyl Phosphate Synthetase 1 Deficiency: Two Case Reports and Review of Literature.

Authors:  Beibei Yan; Chao Wang; Kaihui Zhang; Haiyan Zhang; Min Gao; Yuqiang Lv; Xiaoying Li; Yi Liu; Zhongtao Gai
Journal:  Front Genet       Date:  2019-08-22       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.